Silk Road Medical, Inc (SILK)

20.56 -0.34 (-1.63%) 收市：04:00PM EDT

Silk Road Medical, Inc

1213 Innsbruck Drive
Sunnyvale, CA 94089
United States
408 720 9002
https://silkroadmed.com

版塊: Healthcare
行業: Medical Devices
全職員工: 474

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Charles S. McKhann	CEO & Director	300.77k	無	1969
Mr. Lucas W. Buchanan	CFO & COO	836.87k	4.05M	1978
Mr. Kevin M. Klemz	EVP, Chief Legal Officer & Secretary	665.34k	無	1961
Mr. Andrew S. Davis	Chief Commercial Officer	1.2M	1.45M	1969
Mr. Richard M. Ruedy	Executive Vice President of Clinical, Regulatory Affairs & Quality Assurance	476.27k	無	1967
Ms. Mhairi L. Jones	Chief Accounting Officer & VP of Finance	無	無	1971
Ms. Tammy Leitsinger	Compliance Officer & VP of Medical Affairs	無	無	無
Mr. Jorge O'Hara	Vice President of Marketing, Business Development & Strategy	無	無	無
Ms. Alison Highlander	Vice President of Human Resources	無	無	無
Dr. Sumaira MacDonald M.D., Ph.D.	Executive Medical Director	無	無	無

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.

公司管治

截至 2024年5月1日 止，Silk Road Medical, Inc 的 ISS 管治質素評分為 9。 Pillar 分數正在審核中：8；董事會：5；股東權利：7；現金賠償：10。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。